The British Sarcoma Group (BSG) is the association of the specialist clinicians, nurses and supporting professionals who treat patients with sarcoma in England, Wales, Scotland and Northern Ireland.
The BSG reaches out to colleagues in Ireland, Europe, the USA and Australia through its relationships with individuals and institutions, through collaborative research projects, and international conferences.
All clinicians, nurses and supporting professionals who treat patients with sarcoma in England, Wales, Scotland and Northern Ireland are eligible to join the British Sarcoma Group – we also welcome membership applications from our international colleagues.
Membership is free and gives the following benefits:
We are delighted to announce that we have recently partnered with the National Sarcoma Forum to offer a dedicated strand of the BSG for sarcoma nurses and AHPs. This means that BSG will provide the administrative support needed to run the NSF, and we will work strategically with them to support sarcoma professionals. It also means that as a supported organisation, all NSF members need to be a member of BSG in the first instance.
To find out more about the NSF please visit their dedicated page by clicking HERE.
Becoming a member of the British Sarcoma Group and the National Sarcoma Forum is quick and easy – simply fill in our online Membership Form.
The BSG reaches out to colleagues in Ireland, Europe, the USA & Australia through its relationships with individuals & institutions. This is done through collaborative research projects and international conferences.
The BSG believe it is essential to build on current partnerships and develop new links between medical supply & service companies. This is achieved through special partnership packages which range from conference exhibition and sponsorship through to corporate partner package which provide benefits for organisations all year round.
Find out more about our packages HERE.
“Immedica is a fast-growing private niche pharma group based in Stockholm, Sweden. It has commercial coverage across Europe and the Middle East.
Immedica provides significant know-how and experience from commercialisation of niche/specialty care products across Europe and the Middle East, and the company’s management team has an outstanding track record of operating niche pharma products internationally. Immedica has capabilities to provide optimal access of specialty care medicines to patients with significant medical needs, including key areas such as regulatory affairs, pharmacovigilance, medical affairs, pricing & reimbursement, quality and product distribution.”